Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 132 entries
Sorted by: Best Match Show Resources per page
A Novel Sterol Isolated from a Plant Used by Mayan Traditional Healers Is Effective in Treatment of Visceral Leishmaniasis Caused by Leishmania donovani.

ACS infectious diseases

Gupta G, Peine KJ, Abdelhamid D, Snider H, Shelton AB, Rao L, Kotha SR, Huntsman AC, Varikuti S, Oghumu S, Naman CB, Pan L, Parinandi NL, Papenfuss TL, Kinghorn AD, Bachelder EM, Ainslie KM, Fuchs JR, Satoskar AR.
PMID: 27623316
ACS Infect Dis. 2015 Oct 09;1(10):497-506. doi: 10.1021/acsinfecdis.5b00081. Epub 2015 Sep 21.

Visceral leishmaniasis (VL), caused by the protozoan parasite Leishmania donovani, is a global health problem affecting millions of people worldwide. Treatment of VL largely depends on therapeutic drugs such as pentavalent antimonials, amphotericin B, and others, which have major...

Cite
Gupta G, Peine KJ, Abdelhamid D, et al. A Novel Sterol Isolated from a Plant Used by Mayan Traditional Healers Is Effective in Treatment of Visceral Leishmaniasis Caused by Leishmania donovani. ACS Infect Dis. 2015;1(10):497-506doi: 10.1021/acsinfecdis.5b00081.
Gupta, G., Peine, K. J., Abdelhamid, D., Snider, H., Shelton, A. B., Rao, L., Kotha, S. R., Huntsman, A. C., Varikuti, S., Oghumu, S., Naman, C. B., Pan, L., Parinandi, N. L., Papenfuss, T. L., Kinghorn, A. D., Bachelder, E. M., Ainslie, K. M., Fuchs, J. R., & Satoskar, A. R. (2015). A Novel Sterol Isolated from a Plant Used by Mayan Traditional Healers Is Effective in Treatment of Visceral Leishmaniasis Caused by Leishmania donovani. ACS infectious diseases, 1(10), 497-506. https://doi.org/10.1021/acsinfecdis.5b00081
Gupta, Gaurav, et al. "A Novel Sterol Isolated from a Plant Used by Mayan Traditional Healers Is Effective in Treatment of Visceral Leishmaniasis Caused by Leishmania donovani." ACS infectious diseases vol. 1,10 (2015): 497-506. doi: https://doi.org/10.1021/acsinfecdis.5b00081
Gupta G, Peine KJ, Abdelhamid D, Snider H, Shelton AB, Rao L, Kotha SR, Huntsman AC, Varikuti S, Oghumu S, Naman CB, Pan L, Parinandi NL, Papenfuss TL, Kinghorn AD, Bachelder EM, Ainslie KM, Fuchs JR, Satoskar AR. A Novel Sterol Isolated from a Plant Used by Mayan Traditional Healers Is Effective in Treatment of Visceral Leishmaniasis Caused by Leishmania donovani. ACS Infect Dis. 2015 Oct 09;1(10):497-506. doi: 10.1021/acsinfecdis.5b00081. Epub 2015 Sep 21. PMID: 27623316; PMCID: PMC5730984.
Copy Download .nbib Format: NLM
The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.

JACC. Basic to translational science

Youssef AA, Ross EG, Bolli R, Pepine CJ, Leeper NJ, Yang PC.
PMID: 28580434
JACC Basic Transl Sci. 2016 Oct;1(6):510-523. doi: 10.1016/j.jacbts.2016.06.010.

The recent discovery of human-induced pluripotent stem cells (iPSCs) has revolutionized the field of stem cells. iPSCs have demonstrated that biological development is not an irreversible process and that mature adult somatic cells can be induced to become pluripotent....

Cite
Youssef AA, Ross EG, Bolli R, et al. The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications. JACC Basic Transl Sci. 2016;1(6):510-523doi: 10.1016/j.jacbts.2016.06.010.
Youssef, A. A., Ross, E. G., Bolli, R., Pepine, C. J., Leeper, N. J., & Yang, P. C. (2016). The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications. JACC. Basic to translational science, 1(6), 510-523. https://doi.org/10.1016/j.jacbts.2016.06.010
Youssef, Amr A, et al. "The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications." JACC. Basic to translational science vol. 1,6 (2016): 510-523. doi: https://doi.org/10.1016/j.jacbts.2016.06.010
Youssef AA, Ross EG, Bolli R, Pepine CJ, Leeper NJ, Yang PC. The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications. JACC Basic Transl Sci. 2016 Oct;1(6):510-523. doi: 10.1016/j.jacbts.2016.06.010. PMID: 28580434; PMCID: PMC5451899.
Copy Download .nbib Format: NLM
Sport-Related Concussions: Symptom Recurrence After Return to Exercise.

Orthopaedic journal of sports medicine

O'Brien MJ, Howell DR, Pepin MJ, Meehan WP.
PMID: 29085846
Orthop J Sports Med. 2017 Oct 17;5(10):2325967117732516. doi: 10.1177/2325967117732516. eCollection 2017 Oct.

BACKGROUND: Current guidelines dictate a gradual exercise progression after a concussion; however, it is unclear what proportion of athletes experience a recurrence of symptoms once they are symptom free at rest. Estimating the proportion of athletes and predictors of...

Cite
O'Brien MJ, Howell DR, Pepin MJ, et al. Sport-Related Concussions: Symptom Recurrence After Return to Exercise. Orthop J Sports Med. 2017;5(10):2325967117732516doi: 10.1177/2325967117732516.
O'Brien, M. J., Howell, D. R., Pepin, M. J., & Meehan, W. P. (2017). Sport-Related Concussions: Symptom Recurrence After Return to Exercise. Orthopaedic journal of sports medicine, 5(10), 2325967117732516. https://doi.org/10.1177/2325967117732516
O'Brien, Michael J, et al. "Sport-Related Concussions: Symptom Recurrence After Return to Exercise." Orthopaedic journal of sports medicine vol. 5,10 (2017): 2325967117732516. doi: https://doi.org/10.1177/2325967117732516
O'Brien MJ, Howell DR, Pepin MJ, Meehan WP. Sport-Related Concussions: Symptom Recurrence After Return to Exercise. Orthop J Sports Med. 2017 Oct 17;5(10):2325967117732516. doi: 10.1177/2325967117732516. eCollection 2017 Oct. PMID: 29085846; PMCID: PMC5648095.
Copy Download .nbib Format: NLM
[Treatment of peptic ulcers].

Bulletin medical

LEPINE J.
PMID: 13172577
Bull Med. 1954 Apr 15;68(8):211-2.

No abstract available.

Cite
LEPINE J. Traitement médical des ulcères gastriques. [Treatment of peptic ulcers]. Bull Med. 1954;68(8):211-2
LEPINE, J. (1954). Traitement médical des ulcères gastriques. [Treatment of peptic ulcers]. Bulletin medical, 68(8), 211-2.
LEPINE, J. "Traitement médical des ulcères gastriques." [Treatment of peptic ulcers]. Bulletin medical vol. 68,8 (1954): 211-2.
LEPINE J. Traitement médical des ulcères gastriques. [Treatment of peptic ulcers]. Bull Med. 1954 Apr 15;68(8):211-2. Undetermined. PMID: 13172577.
Copy Download .nbib Format: NLM
[Louis Peisse (1803-1880)].

Annales medico-psychologiques

LEPINE J.
PMID: 12986404
Ann Med Psychol (Paris). 1952 Jun;110(2):82-4.

No abstract available.

Cite
LEPINE J. Louis Peisse (1803-1880). [Louis Peisse (1803-1880)]. Ann Med Psychol (Paris). 1952;110(2):82-4
LEPINE, J. (1952). Louis Peisse (1803-1880). [Louis Peisse (1803-1880)]. Annales medico-psychologiques, 110(2), 82-4.
LEPINE, J. "Louis Peisse (1803-1880)." [Louis Peisse (1803-1880)]. Annales medico-psychologiques vol. 110,2 (1952): 82-4.
LEPINE J. Louis Peisse (1803-1880). [Louis Peisse (1803-1880)]. Ann Med Psychol (Paris). 1952 Jun;110(2):82-4. French. PMID: 12986404.
Copy Download .nbib Format: NLM
[Pathophysiology of pulmonary hypertension].

L'union medicale du Canada

Lepine C.
PMID: 14397016
Union Med Can. 1955 Jun;84(6):675-9.

No abstract available.

Cite
Lepine C. Physiopathologie de l'hypertension pulmonaire. [Pathophysiology of pulmonary hypertension]. Union Med Can. 1955;84(6):675-9
Lepine, C. (1955). Physiopathologie de l'hypertension pulmonaire. [Pathophysiology of pulmonary hypertension]. L'union medicale du Canada, 84(6), 675-9.
Lepine, C. "Physiopathologie de l'hypertension pulmonaire." [Pathophysiology of pulmonary hypertension]. L'union medicale du Canada vol. 84,6 (1955): 675-9.
Lepine C. Physiopathologie de l'hypertension pulmonaire. [Pathophysiology of pulmonary hypertension]. Union Med Can. 1955 Jun;84(6):675-9. French. PMID: 14397016.
Copy Download .nbib Format: NLM
Air quality degradation and its effect on visitor experiences at Great Smoky Mountains National Park.

Environmental monitoring and assessment

Peine J, Eagar C.
PMID: 24249198
Environ Monit Assess. 1989 Jul;12(3):292. doi: 10.1007/BF00394812.

No abstract available.

Cite
Peine J, Eagar C. Air quality degradation and its effect on visitor experiences at Great Smoky Mountains National Park. Environ Monit Assess. 1989;12(3):292doi: 10.1007/BF00394812.
Peine, J., & Eagar, C. (1989). Air quality degradation and its effect on visitor experiences at Great Smoky Mountains National Park. Environmental monitoring and assessment, 12(3), 292. https://doi.org/10.1007/BF00394812
Peine, J, and Eagar, C. "Air quality degradation and its effect on visitor experiences at Great Smoky Mountains National Park." Environmental monitoring and assessment vol. 12,3 (1989): 292. doi: https://doi.org/10.1007/BF00394812
Peine J, Eagar C. Air quality degradation and its effect on visitor experiences at Great Smoky Mountains National Park. Environ Monit Assess. 1989 Jul;12(3):292. doi: 10.1007/BF00394812. PMID: 24249198.
Copy Download .nbib Format: NLM
GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM).

Bioengineering (Basel, Switzerland)

Velpurisiva P, Piel BP, Lepine J, Rai P.
PMID: 30304810
Bioengineering (Basel). 2018 Oct 09;5(4). doi: 10.3390/bioengineering5040083.

Glioblastoma Multiforme (GBM) is a common primary brain cancer with a poor prognosis and a median survival of less than 14 months. Current modes of treatment are associated with deleterious side effects that reduce the life span of the...

Cite
Velpurisiva P, Piel BP, Lepine J, et al. GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM). Bioengineering (Basel). 2018;5(4)doi: 10.3390/bioengineering5040083.
Velpurisiva, P., Piel, B. P., Lepine, J., & Rai, P. (2018). GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM). Bioengineering (Basel, Switzerland), 5(4), . https://doi.org/10.3390/bioengineering5040083
Velpurisiva, Praveena, et al. "GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM)." Bioengineering (Basel, Switzerland) vol. 5,4 (2018). doi: https://doi.org/10.3390/bioengineering5040083
Velpurisiva P, Piel BP, Lepine J, Rai P. GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM). Bioengineering (Basel). 2018 Oct 09;5(4). doi: 10.3390/bioengineering5040083. PMID: 30304810; PMCID: PMC6315921.
Copy Download .nbib Format: NLM
Report of the National Heart, Lung, and Blood Institute Working Group on the Role of Microbiota in Blood Pressure Regulation: Current Status and Future Directions.

Hypertension (Dallas, Tex. : 1979)

Raizada MK, Joe B, Bryan NS, Chang EB, Dewhirst FE, Borisy GG, Galis ZS, Henderson W, Jose PA, Ketchum CJ, Lampe JW, Pepine CJ, Pluznick JL, Raj D, Seals DR, Gioscia-Ryan RA, Tang WHW, Oh YS.
PMID: 28760940
Hypertension. 2017 Jul 31; doi: 10.1161/HYPERTENSIONAHA.117.09699. Epub 2017 Jul 31.

No abstract available.

Cite
Raizada MK, Joe B, Bryan NS, et al. Report of the National Heart, Lung, and Blood Institute Working Group on the Role of Microbiota in Blood Pressure Regulation: Current Status and Future Directions. Hypertension. 2017;doi: 10.1161/HYPERTENSIONAHA.117.09699.
Raizada, M. K., Joe, B., Bryan, N. S., Chang, E. B., Dewhirst, F. E., Borisy, G. G., Galis, Z. S., Henderson, W., Jose, P. A., Ketchum, C. J., Lampe, J. W., Pepine, C. J., Pluznick, J. L., Raj, D., Seals, D. R., Gioscia-Ryan, R. A., Tang, W. H. W., & Oh, Y. S. (2017). Report of the National Heart, Lung, and Blood Institute Working Group on the Role of Microbiota in Blood Pressure Regulation: Current Status and Future Directions. Hypertension (Dallas, Tex. : 1979), . https://doi.org/10.1161/HYPERTENSIONAHA.117.09699
Raizada, Mohan K, et al. "Report of the National Heart, Lung, and Blood Institute Working Group on the Role of Microbiota in Blood Pressure Regulation: Current Status and Future Directions." Hypertension (Dallas, Tex. : 1979) vol. (2017). doi: https://doi.org/10.1161/HYPERTENSIONAHA.117.09699
Raizada MK, Joe B, Bryan NS, Chang EB, Dewhirst FE, Borisy GG, Galis ZS, Henderson W, Jose PA, Ketchum CJ, Lampe JW, Pepine CJ, Pluznick JL, Raj D, Seals DR, Gioscia-Ryan RA, Tang WHW, Oh YS. Report of the National Heart, Lung, and Blood Institute Working Group on the Role of Microbiota in Blood Pressure Regulation: Current Status and Future Directions. Hypertension. 2017 Jul 31; doi: 10.1161/HYPERTENSIONAHA.117.09699. Epub 2017 Jul 31. PMID: 28760940; PMCID: PMC5792379.
Copy Download .nbib Format: NLM
Systolic blood pressure target: Have we identified the optimal target yet?.

Journal of public health and emergency

Elgendy IY, Pepine CJ.
PMID: 30148257
J Public Health Emerg. 2017 Jun;1. doi: 10.21037/jphe.2017.06.04. Epub 2017 Jun 19.

No abstract available.

Cite
Elgendy IY, Pepine CJ. Systolic blood pressure target: Have we identified the optimal target yet?. J Public Health Emerg. 2017;1doi: 10.21037/jphe.2017.06.04.
Elgendy, I. Y., & Pepine, C. J. (2017). Systolic blood pressure target: Have we identified the optimal target yet?. Journal of public health and emergency, 1. https://doi.org/10.21037/jphe.2017.06.04
Elgendy, Islam Y, and Pepine, Carl J. "Systolic blood pressure target: Have we identified the optimal target yet?." Journal of public health and emergency vol. 1 (2017). doi: https://doi.org/10.21037/jphe.2017.06.04
Elgendy IY, Pepine CJ. Systolic blood pressure target: Have we identified the optimal target yet?. J Public Health Emerg. 2017 Jun;1. doi: 10.21037/jphe.2017.06.04. Epub 2017 Jun 19. PMID: 30148257; PMCID: PMC6107304.
Copy Download .nbib Format: NLM
Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.

International journal of cardiology

Mehta PK, Quesada O, Al-Badri A, Fleg JL, Volgman AS, Pepine CJ, Merz CNB, Shaw LJ.
PMID: 34902504
Int J Cardiol. 2022 Feb 01;348:1-8. doi: 10.1016/j.ijcard.2021.12.013. Epub 2021 Dec 11.

A large proportion of patients with suspected obstructive coronary artery disease (CAD) is found to have ischemia with no obstructive coronary artery disease (INOCA). Based on current evidence, these patients are at increased risk of adverse cardiovascular events, even...

Cite
Mehta PK, Quesada O, Al-Badri A, et al. Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease. Int J Cardiol. 2021;348:1-8doi: 10.1016/j.ijcard.2021.12.013.
Mehta, P. K., Quesada, O., Al-Badri, A., Fleg, J. L., Volgman, A. S., Pepine, C. J., Merz, C. N. B., & Shaw, L. J. (2022). Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease. International journal of cardiology, 3481-8. https://doi.org/10.1016/j.ijcard.2021.12.013
Mehta, Puja K, et al. "Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease." International journal of cardiology vol. 348 (2022): 1-8. doi: https://doi.org/10.1016/j.ijcard.2021.12.013
Mehta PK, Quesada O, Al-Badri A, Fleg JL, Volgman AS, Pepine CJ, Merz CNB, Shaw LJ. Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease. Int J Cardiol. 2022 Feb 01;348:1-8. doi: 10.1016/j.ijcard.2021.12.013. Epub 2021 Dec 11. PMID: 34902504.
Copy Download .nbib Format: NLM
One-year outcomes in individual domains of the cerebral performance category extended.

Resuscitation plus

Flickinger KL, Jaramillo S, Repine MJ, Koller AC, Holm M, Skidmore E, Callaway C, Rittenberger JC.
PMID: 34934994
Resusc Plus. 2021 Dec 06;8:100184. doi: 10.1016/j.resplu.2021.100184. eCollection 2021 Dec.

BACKGROUND: Physical and cognitive impairments are common after cardiac arrest, and recovery varies. This study assessed recovery of individual domains of the Cerebral Performance Category- Extended (CPC-E) 1-year after cardiac arrest. We hypothesized patients would have recovery in all...

Cite
Flickinger KL, Jaramillo S, Repine MJ, et al. One-year outcomes in individual domains of the cerebral performance category extended. Resusc Plus. 2021;8:100184doi: 10.1016/j.resplu.2021.100184.
Flickinger, K. L., Jaramillo, S., Repine, M. J., Koller, A. C., Holm, M., Skidmore, E., Callaway, C., & Rittenberger, J. C. (2021). One-year outcomes in individual domains of the cerebral performance category extended. Resuscitation plus, 8100184. https://doi.org/10.1016/j.resplu.2021.100184
Flickinger, Katharyn L, et al. "One-year outcomes in individual domains of the cerebral performance category extended." Resuscitation plus vol. 8 (2021): 100184. doi: https://doi.org/10.1016/j.resplu.2021.100184
Flickinger KL, Jaramillo S, Repine MJ, Koller AC, Holm M, Skidmore E, Callaway C, Rittenberger JC. One-year outcomes in individual domains of the cerebral performance category extended. Resusc Plus. 2021 Dec 06;8:100184. doi: 10.1016/j.resplu.2021.100184. eCollection 2021 Dec. PMID: 34934994; PMCID: PMC8661046.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 132 entries